Skip NavigationSkip to Content

Effects of selenium supplementation on expression of glutathione peroxidase isoforms in cultured human lung adenocarcinoma cell lines

  1. Author:
    Romanowska, M.
    Kikawa, K. D.
    Fields, J. R.
    Maciag, A.
    North, S. L.
    Shiao, Y. H.
    Kasprzak, K. S.
    Anderson, L. M.
  2. Author Address

    Natl Canc Inst, Comparat Carcinogenesis Lab, Frederick, MD 21702 USA.;Romanowska, M, Natl Canc Inst, Comparat Carcinogenesis Lab, Bldg 538, Frederick, MD 21702 USA.;mromanowska@ncifcrf.gov
    1. Year: 2007
    2. Date: Jan
  1. Journal: Lung Cancer
    1. 55
    2. 1
    3. Pages: 35-42
  2. Type of Article: Article
  3. ISSN: 0169-5002
  1. Abstract:

    Selenium is an essential nutrient, a component of several anti-oxidant enzymes, and a possible factor in cancer risk, including lung cancer. We determined the subtoxic range of selenium concentration (as sodium setenite) required to increase and maintain the expression of anti-oxidant selenoproteins gluthathione peroxidases GPX1 and GPX4 at a constant level in cultures of human lung adenocarcinoma cell lines (H460, H1703 and H1944) and in HPL1D, a non-transformed lung epithelial cell line. Selenium dose-dependently increased GPX1 protein expression 1.8-fold in HPL1D cells and similar to 40-fold in H460 and H1944 cancer cells, with maximum effects at 20-40 nM. GPX4 protein was also increased, but more so in HPL1D (five-fold) than in H460 or H1944 cells (two- to three-fold). GPX1 mRNA showed similar patterns but differences of lesser magnitude. GPX1 protein and activity level was not consistently detectable in H1703 cells, with or without Se supplementation; its mRNA was present but very low. GPX4 protein level was also tow in H1703 cells, but was markedly increased by selenium supplementation (48-fold). These results confirm a rote for selenium in risk of lung cancer and the independent regulation of GPX1 and GPX4. Characterization of individual tumors with regard to GPX1 and GPX4 tevels and regulation might be useful for interpretation of clinical studies on effects of selenium in lung cancer risk. (c) 2006 Elsevier Ireland Ltd. All rights reserved.

    See More

External Sources

  1. DOI: 10.1016/j.lungcan.2006.09.007
  2. PMID: 17052796
  3. WOS: 000244103200004

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel